Research programme: genomic therapeutics - Evotec SE/Toray
Latest Information Update: 26 Sep 2019
At a glance
- Originator Evotec AG; Toray
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 08 Sep 2007 Discontinued - Preclinical for Undefined indication in Germany (unspecified route)
- 08 Sep 2007 Discontinued - Preclinical for Undefined indication in Japan (unspecified route)
- 11 Feb 2004 Preclinical trials in Undefined indication in Germany (unspecified route)